Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

If You're In Your 20's, Consider Buying These 3 Healthcare Stocks
If You're In Your 20's, Consider Buying These 3 Healthcare Stocks

If you are in your 20's you likely have more than four decades ahead of you to invest before hitting retirement. Some might suggest that now is the time to take an aggressive investment stance, but

EQS-News: E.ON continues to grow and increases investments
EQS-News: E.ON continues to grow and increases investments
EQS-News: E.ON continues to grow and increases investments
EQS-News: Hannover Re increases half-year result and further strengthens balance sheet resilience
EQS-News: Hannover Re increases half-year result and further strengthens balance sheet resilience
EQS-News: Hannover Re increases half-year result and further strengthens balance sheet resilience
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
2 Magnificent Stocks to Buy That Are Near 52-Week Lows

The S&P 500 has a miserly yield of 1.2%. The average healthcare stock's yield is about 1.8%. Compared to that, Merck's (NYSE: MRK) roughly 4% yield is highly attractive. And LTC Properties' (NYSE:

3 High-Yield Healthcare Stocks to Buy Hand Over Fist in August
3 High-Yield Healthcare Stocks to Buy Hand Over Fist in August

If you are looking at healthcare stocks for dividend ideas in August, don't get too caught up on the sector's low 1.8% dividend yield. You can do much better than that without having to take on huge

Better Buy: Rivian vs. Ford
Better Buy: Rivian vs. Ford

The electric vehicle (EV) revolution continues to unfold, but not every automaker is on equal footing. Furthermore, internal combustion engines still dominate the market. Investors looking to gain

Puma (PBYI) Q2 Revenue Rises 11%
Puma (PBYI) Q2 Revenue Rises 11%

Puma Biotechnology (NASDAQ:PBYI), a pharmaceutical company focused on therapies for cancer, released its second quarter 2025 earnings on August 7, 2025. The company posted non-GAAP earnings per

EQS-News: Henkel expects further profitable growth in fiscal 2025
EQS-News: Henkel expects further profitable growth in fiscal 2025
EQS-News: Henkel expects further profitable growth in fiscal 2025
EQS-News: Allianz announces excellent performance and is fully on track for full-year ambitions
EQS-News: Allianz announces excellent performance and is fully on track for full-year ambitions
EQS-News: Allianz announces excellent performance and is fully on track for full-year ambitions
EQS-News: Vonovia reports 11% growth in earnings and raises EBT guidance for 2025 by €100 million
EQS-News: Vonovia reports 11% growth in earnings and raises EBT guidance for 2025 by €100 million
EQS-News: Vonovia reports 11% growth in earnings and raises EBT guidance for 2025 by €100 million
Linde Q2 EPS Up 6%
Linde Q2 EPS Up 6%

Linde (NASDAQ:LIN), a global leader in industrial gases and engineering, reported second-quarter 2025 earnings on August 1, 2025. The company delivered results ahead of market expectations, with

EQS-Adhoc: Beiersdorf Aktiengesellschaft: Beiersdorf adjusts forecast for the full year 2025
EQS-Adhoc: Beiersdorf Aktiengesellschaft: Beiersdorf adjusts forecast for the full year 2025
EQS-Adhoc: Beiersdorf Aktiengesellschaft: Beiersdorf adjusts forecast for the full year 2025
EQS-News: Zalando Delivers Strong Growth and Profit Rise in Q2, Rolls Out AI-Powered Discovery Feed to Further Inspire Growing Customer Base
EQS-News: Zalando Delivers Strong Growth and Profit Rise in Q2, Rolls Out AI-Powered Discovery Feed to Further Inspire Growing Customer Base
EQS-News: Zalando Delivers Strong Growth and Profit Rise in Q2, Rolls Out AI-Powered Discovery Feed to Further Inspire Growing Customer Base
EQS-Adhoc: Zalando SE: Adjustment of guidance for the 2025 financial year taking into account the strategic combination with ABOUT YOU
EQS-Adhoc: Zalando SE: Adjustment of guidance for the 2025 financial year taking into account the strategic combination with ABOUT YOU
EQS-Adhoc: Zalando SE: Adjustment of guidance for the 2025 financial year taking into account the strategic combination with ABOUT YOU
EQS-News: Continental Continues Solid Development and Further Improves Automotive Earnings
EQS-News: Continental Continues Solid Development and Further Improves Automotive Earnings
EQS-News: Continental Continues Solid Development and Further Improves Automotive Earnings
EQS-News: Infineon: Q3 FY 2025 revenue as guided, Segment Result above forecast. Further growth expected in the current quarter despite ongoing tariff uncertainties and weaker US dollar
EQS-News: Infineon: Q3 FY 2025 revenue as guided, Segment Result above forecast. Further growth expected in the current quarter despite ongoing tariff uncertainties and weaker US dollar
EQS-News: Infineon: Q3 FY 2025 revenue as guided, Segment Result above forecast. Further growth expected in the current quarter despite ongoing tariff uncertainties and weaker US dollar
EQS-News: PUMA appoints Archie McEachern as Vice President Basketball 
EQS-News: PUMA appoints Archie McEachern as Vice President Basketball 
EQS-News: PUMA appoints Archie McEachern as Vice President Basketball 
3 High-Yielding Dividend Stocks That Are Trading Near Their 52-Week Lows
3 High-Yielding Dividend Stocks That Are Trading Near Their 52-Week Lows

The S&P 500 (SNPINDEX: ^GSPC) is offering investors a tiny yield of just 1.2% today. If you think you are being starved of dividend income, well, that's because you are. But you can do much better

EQS-Adhoc: Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings guidance for 2025 and establishes additional provisions for litigation in the United States
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings guidance for 2025 and establishes additional provisions for litigation in the United States
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings guidance for 2025 and establishes additional provisions for litigation in the United States
EQS-Adhoc: Daimler Truck Holding AG: Strong Q2 performance - reduced outlook for 2025 : https://upload.wikimedia.org/wikipedia/commons/thumb/5/55/Daimler_Truck_Logo.svg/1024px-Daimler_Truck_Logo.svg.png
EQS-Adhoc: Daimler Truck Holding AG: Strong Q2 performance - reduced outlook for 2025
EQS-Adhoc: Daimler Truck Holding AG: Strong Q2 performance - reduced outlook for 2025
EQS-News: PUMA appoints Andreas Hubert as Chief Operating Officer
EQS-News: PUMA appoints Andreas Hubert as Chief Operating Officer
EQS-News: PUMA appoints Andreas Hubert as Chief Operating Officer
EQS-Adhoc: Airbus SE: Airbus reports Half-Year (H1) 2025 results
EQS-Adhoc: Airbus SE: Airbus reports Half-Year (H1) 2025 results
EQS-Adhoc: Airbus SE: Airbus reports Half-Year (H1) 2025 results
EQS-News: Symrise Reports First Half 2025 Results
EQS-News: Symrise Reports First Half 2025 Results
EQS-News: Symrise Reports First Half 2025 Results
Why Merck Stock Slipped Today
Why Merck Stock Slipped Today

On Tuesday, Merck (NYSE: MRK) wasn't one of the better-performing pharmaceutical stocks. In contrast to certain peers, the company's share price declined following the release of second-quarter

Merck Posts Q2 EPS Beat Revenue Slips
Merck Posts Q2 EPS Beat Revenue Slips

Merck (NYSE:MRK), a leading developer of prescription medicines, vaccines, and animal health products, released its second-quarter 2025 results on July 29, 2025. The most notable news was a beat on